Literature DB >> 16424713

Sepsis in European intensive care units: results of the SOAP study.

Jean-Louis Vincent1, Yasser Sakr, Charles L Sprung, V Marco Ranieri, Konrad Reinhart, Herwig Gerlach, Rui Moreno, Jean Carlet, Jean-Roger Le Gall, Didier Payen.   

Abstract

OBJECTIVE: To better define the incidence of sepsis and the characteristics of critically ill patients in European intensive care units.
DESIGN: Cohort, multiple-center, observational study.
SETTING: One hundred and ninety-eight intensive care units in 24 European countries. PATIENTS: All new adult admissions to a participating intensive care unit between May 1 and 15, 2002.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Demographic data, comorbid diseases, and clinical and laboratory data were collected prospectively. Patients were followed up until death, until hospital discharge, or for 60 days. Of 3,147 adult patients, with a median age of 64 yrs, 1,177 (37.4%) had sepsis; 777 (24.7%) of these patients had sepsis on admission. In patients with sepsis, the lung was the most common site of infection (68%), followed by the abdomen (22%). Cultures were positive in 60% of the patients with sepsis. The most common organisms were Staphylococcus aureus (30%, including 14% methicillin-resistant), Pseudomonas species (14%), and Escherichia coli (13%). Pseudomonas species was the only microorganism independently associated with increased mortality rates. Patients with sepsis had more severe organ dysfunction, longer intensive care unit and hospital lengths of stay, and higher mortality rate than patients without sepsis. In patients with sepsis, age, positive fluid balance, septic shock, cancer, and medical admission were the important prognostic variables for intensive care unit mortality. There was considerable variation between countries, with a strong correlation between the frequency of sepsis and the intensive care unit mortality rates in each of these countries.
CONCLUSIONS: This large pan-European study documents the high frequency of sepsis in critically ill patients and shows a close relationship between the proportion of patients with sepsis and the intensive care unit mortality in the various countries. In addition to age, a positive fluid balance was among the strongest prognostic factors for death. Patients with intensive care unit acquired sepsis have a worse outcome despite similar severity scores on intensive care unit admission.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16424713     DOI: 10.1097/01.ccm.0000194725.48928.3a

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  778 in total

Review 1.  Immune therapy in sepsis: Are we ready to try again?

Authors:  Roger Davies; Kieran O'Dea; Anthony Gordon
Journal:  J Intensive Care Soc       Date:  2018-04-04

2.  Platelet aggregation in severe sepsis.

Authors:  Gábor Woth; Adrienn Varga; Subhamay Ghosh; Miklós Krupp; Tamás Kiss; Lajos Bogár; Diana Mühl
Journal:  J Thromb Thrombolysis       Date:  2011-01       Impact factor: 2.300

3.  Understanding the potential role of statins in pneumonia and sepsis.

Authors:  Sachin Yende; Eric B Milbrandt; John A Kellum; Lan Kong; Russell L Delude; Lisa A Weissfeld; Derek C Angus
Journal:  Crit Care Med       Date:  2011-08       Impact factor: 7.598

4.  Impact of nosocomial polymicrobial bloodstream infections on the outcome in critically ill patients.

Authors:  S Sancho; A Artero; R Zaragoza; J J Camarena; R González; J M Nogueira
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-14       Impact factor: 3.267

5.  Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis.

Authors:  Simon Finfer; Suzanne McEvoy; Rinaldo Bellomo; Colin McArthur; John Myburgh; Robyn Norton
Journal:  Intensive Care Med       Date:  2010-10-06       Impact factor: 17.440

Review 6.  Advances in the management of sepsis and the understanding of key immunologic defects.

Authors:  Lee P Skrupky; Paul W Kerby; Richard S Hotchkiss
Journal:  Anesthesiology       Date:  2011-12       Impact factor: 7.892

7.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

8.  Liberal Versus Restrictive Intravenous Fluid Therapy for Early Septic Shock: Rationale for a Randomized Trial.

Authors:  Wesley H Self; Matthew W Semler; Rinaldo Bellomo; Samuel M Brown; Bennett P deBoisblanc; Matthew C Exline; Adit A Ginde; Colin K Grissom; David R Janz; Alan E Jones; Kathleen D Liu; Stephen P J Macdonald; Chadwick D Miller; Pauline K Park; Lora A Reineck; Todd W Rice; Jay S Steingrub; Daniel Talmor; Donald M Yealy; Ivor S Douglas; Nathan I Shapiro
Journal:  Ann Emerg Med       Date:  2018-05-10       Impact factor: 5.721

9.  Immature platelet fraction in predicting sepsis in critically ill patients.

Authors:  Roberto Alberto De Blasi; Patrizia Cardelli; Alessandro Costante; Micol Sandri; Marco Mercieri; Roberto Arcioni
Journal:  Intensive Care Med       Date:  2012-10-24       Impact factor: 17.440

10.  Importance of Pharmacy Involvement in the Treatment of Sepsis.

Authors:  Joseph B Cavanaugh; Jesse B Sullivan; Nicole East; Jessica N Nodzon
Journal:  Hosp Pharm       Date:  2017-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.